---
category: news
title: "Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?"
excerpt: "Schrondinger spent $1.85 to generate every $1 in drug discovery revenue in 2021. Investors need to see larger-scale operations translate into improved margins in 2023 and beyond. If the company delivers,"
publishedDateTime: 2022-06-13T17:32:00Z
originalUrl: "https://www.thestreet.com/investing/will-schrodinger-succeed-2022"
webUrl: "https://www.thestreet.com/investing/will-schrodinger-succeed-2022"
ampWebUrl: "https://www.thestreet.com/.amp/investing/will-schrodinger-succeed-2022"
cdnAmpWebUrl: "https://www-thestreet-com.cdn.ampproject.org/c/s/www.thestreet.com/.amp/investing/will-schrodinger-succeed-2022"
type: article
quality: 57
heat: 57
published: false

provider:
  name: TheStreet.com
  domain: thestreet.com

topics:
  - AI

images:
  - url: "https://www.thestreet.com/.image/c_fill%2Ccs_srgb%2Cfl_progressive%2Ch_400%2Cq_auto:good%2Cw_620/MTY4NjUxNTA4NjUxNTMzOTU5/negotiators-want-to-secure-a-nafta-deal-by-early-next-year.jpg"
    width: 620
    height: 400
    isCached: true

secured: "iveQNJBZhbPF3wp7j7GEZPySD7puIK0BqPYCc4wBh1Wzdc5OC4f5s7iXzOKcZ7EhLUEZB501VKscnAahTpX0m/qk8WqjuKYBRlq8VrGVrQPiaYEpTEhZyrhzfDK0rF6BgUzAF5gS5AxZ9le97jMTPICLMlZHu20U7/VrvItZOrp/mEsX3+yzDlRGAgP5DfE9rCpijFxoLXlMqhD4nKayij5sbJFxMKPN/lOtoGWMg6gPxAC33zbtcNCFagaO99MjBR35nWx6seHV5e9WlPhhcPWA+Qi5UOPH/4/MdvHKpn0LWkaoR1QYEEtxFPs6YZDEbZRfpb6uhCOVS31I21TbrYiJym5eaby/KudxRxOK6TA=;3w1MB2evTZHcFoMm7x4Fpg=="
---

